Effect of different strength of intralesional triamcinolone acetonide in alopecia areata.
Phase 3
- Conditions
- Health Condition 1: L639- Alopecia areata, unspecified
- Registration Number
- CTRI/2024/02/063138
- Lead Sponsor
- Institute of Medical Sciences BH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. All clinically diagnosed cases of alopecia areata with duration of illness more than 4 months.
Exclusion Criteria
1. Patients with existing skin diseases affecting the scalp such as psoriasis or seborrheic dermatitis.
2. Patients with evidence of adrenal cortex abnormality.
3. Patients known to be HIV or hepatitis B, C positive or otherwise immunocompromised
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method